Medical Director Articles

The term "article" is used to describe any bulletin article, web site article, educational handout or any other non-LCD document intended for public release that contains coverage/coding statements or medical review related billing or claims considerations.

Articles address local coverage, coding or medical review related billing and claims considerations, and may include any newly developed educational materials, coding instructions or clarification of existing medical review related billing or claims policy.

The article listing will continue to expand as additions are made.

Last Updated $dateUtil.getDate( $modifieddate , "MMM dd , yyyy" , $locale , $tzone )
Articles Source Posted
Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies (A57892) - R7 - Effective January 1, 2024 ene 18, 2024
Billing and Coding: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer (A58187) - R7 - Effective January 1, 2024 ene 18, 2024
Local Coverage Determinations (LCDs) Finalized - Effective February 25, 2024 ene 15, 2024
Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers (A58456) - R6- January 1, 2024 ene 11, 2024
Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT) (A57527) - R16- January 1, 2024 ene 11, 2024